Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federico Turkheimer

Showing results (51-60 of 115) with videos related to

Pageof 12
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 22, 2020
A potential biomarker for treatment stratification in psychosis: evaluation of an [<sup>18</sup>F] FDOPA PET imaging approachMattia Veronese, Barbara Santangelo, Sameer Jauhar, et al.
The American Journal of Psychiatry|July 20, 2011
Dopamine synthesis capacity before onset of psychosis: a prospective [18F]-DOPA PET imaging studyOliver D Howes, Subrata K Bose, Federico Turkheimer, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 23, 2002
5-Hydroxytryptamine1A receptor occupancy by novel full antagonist 2-[4-[4-(7-chloro-2,3-dihydro-1,4-benzdioxyn-5-yl)-1-piperazinyl]butyl]-1,2-benzisothiazol-3-(2H)-one-1,1-dioxide: a[11C][O-methyl-3H]-N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide trihydrochloride (WAY-100635) positron emission tomography study in humansEugenii A Rabiner, Martin R Wilkins, Federico Turkheimer, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|February 10, 2017
Validation of an automatic reference region extraction for the quantification of [<sup>18</sup>F]DPA-714 in dynamic brain PET studiesDaniel García-Lorenzo, Sonia Lavisse, Claire Leroy, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 11, 2021
Altered nuclear architecture in blood cells from Huntington's disease patientsInês J de Castro, Brian Toner, Sheila Q Xie, et al.
Cell Death & Disease|June 23, 2017
A role for TSPO in mitochondrial Ca<sup>2+</sup> homeostasis and redox stress signalingJemma Gatliff, Daniel A East, Aarti Singh, et al.
Journal of Neuroinflammation|February 14, 2023
Exploring the neuroprotective effects of montelukast on brain inflammation and metabolism in a rat model of quinolinic acid-induced striatal neurotoxicityMargherita Tassan Mazzocco, Valentina Murtaj, Daniel Martins, et al.
Neurobiology of Disease|September 27, 2005
In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's diseaseAlexander Gerhard, Nicola Pavese, Gary Hotton, et al.
Molecular Imaging and Biology|May 5, 2025
Radiomic Analysis of Striatal [<sup>18</sup>F]FDOPA PET Imaging in Patients with Psychosis for the Identification of Antipsychotic ResponseAstrid Schiulaz, Giovanna Nordio, Alessio Giacomel, et al.
Synapse (New York, N.Y.)|February 15, 2020
Investigating the effects of ebselen, a potential new lithium mimetic, on glutamate transmissionFilipa Mota, Teresa Sementa, Carlotta Taddei, et al.
Pageof 12

Showing results (51-60 of 115) with videos related to

Sort By:
Pageof 12
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 22, 2020
A potential biomarker for treatment stratification in psychosis: evaluation of an [<sup>18</sup>F] FDOPA PET imaging approachMattia Veronese, Barbara Santangelo, Sameer Jauhar, et al.
The American Journal of Psychiatry|July 20, 2011
Dopamine synthesis capacity before onset of psychosis: a prospective [18F]-DOPA PET imaging studyOliver D Howes, Subrata K Bose, Federico Turkheimer, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 23, 2002
5-Hydroxytryptamine1A receptor occupancy by novel full antagonist 2-[4-[4-(7-chloro-2,3-dihydro-1,4-benzdioxyn-5-yl)-1-piperazinyl]butyl]-1,2-benzisothiazol-3-(2H)-one-1,1-dioxide: a[11C][O-methyl-3H]-N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide trihydrochloride (WAY-100635) positron emission tomography study in humansEugenii A Rabiner, Martin R Wilkins, Federico Turkheimer, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|February 10, 2017
Validation of an automatic reference region extraction for the quantification of [<sup>18</sup>F]DPA-714 in dynamic brain PET studiesDaniel García-Lorenzo, Sonia Lavisse, Claire Leroy, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 11, 2021
Altered nuclear architecture in blood cells from Huntington's disease patientsInês J de Castro, Brian Toner, Sheila Q Xie, et al.
Cell Death & Disease|June 23, 2017
A role for TSPO in mitochondrial Ca<sup>2+</sup> homeostasis and redox stress signalingJemma Gatliff, Daniel A East, Aarti Singh, et al.
Journal of Neuroinflammation|February 14, 2023
Exploring the neuroprotective effects of montelukast on brain inflammation and metabolism in a rat model of quinolinic acid-induced striatal neurotoxicityMargherita Tassan Mazzocco, Valentina Murtaj, Daniel Martins, et al.
Neurobiology of Disease|September 27, 2005
In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's diseaseAlexander Gerhard, Nicola Pavese, Gary Hotton, et al.
Molecular Imaging and Biology|May 5, 2025
Radiomic Analysis of Striatal [<sup>18</sup>F]FDOPA PET Imaging in Patients with Psychosis for the Identification of Antipsychotic ResponseAstrid Schiulaz, Giovanna Nordio, Alessio Giacomel, et al.
Synapse (New York, N.Y.)|February 15, 2020
Investigating the effects of ebselen, a potential new lithium mimetic, on glutamate transmissionFilipa Mota, Teresa Sementa, Carlotta Taddei, et al.
Pageof 12